Real-time enrollment status for this suspected epithelial ovarian, fallopian tube, or primary peritoneal cancer clinical trial
Current Status
Recruiting
Checked: July 17, 2026 at 12:19 AM UTC
| NCT Number | NCT02637934 |
| Recruiting Status | Recruiting |
| Condition | Suspected Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer |
| Phase | PHASE1 |
| Target Enrollment | 35 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Abramson Cancer Center at Penn Medicine |
| Last Updated on CT.gov | April 7, 2026 (Apr 7, 2026) |
As of July 17, 2026: Clinical trial NCT02637934 is currently recruiting participants. This phase1 study for suspected epithelial ovarian, fallopian tube, or primary peritoneal cancer is actively seeking new participants at 1 location across the United States. The study is sponsored by Abramson Cancer Center at Penn Medicine. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT02637934 is actively recruiting participants as of July 17, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT02637934 was last updated Apr 7, 2026 (April 7, 2026). HelloStudys verifies this status automatically.